Anglo American plc (NGLOY)
OTCMKTS · Delayed Price · Currency is USD
14.09
-0.10 (-0.70%)
Jul 31, 2025, 9:45 AM EDT
Orchard Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -4,275 | -3,068 | 283 | 4,514 | 8,562 | 2,089 | Upgrade |
Depreciation & Amortization | 3,133 | 3,072 | 2,685 | 2,446 | 2,715 | 2,597 | Upgrade |
Loss (Gain) From Sale of Assets | 77 | 77 | - | - | - | 22 | Upgrade |
Asset Writedown & Restructuring Costs | 4,913 | 4,913 | - | - | - | 1,000 | Upgrade |
Loss (Gain) on Equity Investments | -168 | -134 | -378 | -641 | -634 | -103 | Upgrade |
Stock-Based Compensation | 177 | 189 | 175 | 215 | 189 | 166 | Upgrade |
Other Operating Activities | 2,344 | 1,471 | 4,873 | 5,083 | 5,135 | 2,255 | Upgrade |
Change in Accounts Receivable | 261 | 989 | -384 | -374 | -637 | -1,035 | Upgrade |
Change in Inventory | 1,156 | 779 | 2 | -1,776 | 328 | -1,560 | Upgrade |
Change in Accounts Payable | 55 | 19 | -785 | 48 | 1,368 | 1,061 | Upgrade |
Change in Other Net Operating Assets | -190 | -204 | 25 | 250 | -303 | 126 | Upgrade |
Operating Cash Flow | 6,357 | 8,103 | 6,496 | 9,765 | 16,723 | 6,618 | Upgrade |
Operating Cash Flow Growth | -19.26% | 24.74% | -33.48% | -41.61% | 152.69% | -13.65% | Upgrade |
Capital Expenditures | -4,967 | -5,532 | -5,876 | -6,191 | -5,732 | -4,647 | Upgrade |
Sale of Property, Plant & Equipment | 16 | 13 | 16 | 7 | 17 | 7 | Upgrade |
Cash Acquisitions | - | - | -10 | - | - | -520 | Upgrade |
Divestitures | 128 | 177 | 210 | 564 | 63 | 384 | Upgrade |
Sale (Purchase) of Intangibles | -51 | -80 | -133 | -129 | -68 | -63 | Upgrade |
Investment in Securities | -67 | -56 | -78 | -179 | -6 | 53 | Upgrade |
Other Investing Activities | 210 | 343 | 311 | 111 | 168 | 46 | Upgrade |
Investing Cash Flow | -4,731 | -5,135 | -5,560 | -5,817 | -5,558 | -4,740 | Upgrade |
Long-Term Debt Issued | - | 5,295 | 3,063 | 3,500 | 1,968 | 5,087 | Upgrade |
Long-Term Debt Repaid | - | -3,875 | -1,959 | -1,364 | -2,890 | -3,355 | Upgrade |
Net Debt Issued (Repaid) | -3,363 | 1,420 | 1,104 | 2,136 | -922 | 1,732 | Upgrade |
Repurchase of Common Stock | -72 | -135 | -274 | -527 | -1,084 | -385 | Upgrade |
Common Dividends Paid | -793 | -1,026 | -1,564 | -2,937 | -3,047 | -904 | Upgrade |
Other Financing Activities | -152 | -1,099 | -2,489 | -2,428 | -3,303 | -1,159 | Upgrade |
Financing Cash Flow | -4,380 | -840 | -3,223 | -4,368 | -9,356 | -716 | Upgrade |
Foreign Exchange Rate Adjustments | -10 | -68 | -39 | -237 | -260 | 11 | Upgrade |
Net Cash Flow | -2,764 | 2,060 | -2,326 | -657 | 1,549 | 1,173 | Upgrade |
Free Cash Flow | 1,390 | 2,571 | 620 | 3,574 | 10,991 | 1,971 | Upgrade |
Free Cash Flow Growth | -46.17% | 314.68% | -82.65% | -67.48% | 457.64% | -32.50% | Upgrade |
Free Cash Flow Margin | 5.21% | 9.42% | 2.02% | 10.18% | 26.45% | 7.75% | Upgrade |
Free Cash Flow Per Share | 2.25 | 2.41 | 0.58 | 3.31 | 9.98 | 1.79 | Upgrade |
Cash Interest Paid | 851 | 851 | 701 | 420 | 433 | 471 | Upgrade |
Cash Income Tax Paid | 1,574 | 1,574 | 2,001 | 2,726 | 4,341 | 1,606 | Upgrade |
Levered Free Cash Flow | -1,408 | -647.75 | -975.38 | 948.5 | 9,249 | 598.75 | Upgrade |
Unlevered Free Cash Flow | -714.25 | 58.5 | -382.88 | 1,242 | 9,495 | 921.25 | Upgrade |
Change in Net Working Capital | 2,701 | 667 | 1,164 | 1,905 | -1,574 | 1,264 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.